Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Ross

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2019
Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term InfantsJacqueline G Gerhart, Kevin M Watt, Andrea Edginton, et al.
The Journal of Urology|August 6, 2018
A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III)E David Crawford, Phillip J Koo, Neal Shore, et al.
Neoplasia (New York, N.Y.)|August 28, 2016
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate CancerSudhanshu Shukla, Xiang Zhang, Yashar S Niknafs, et al.
BMC Cancer|July 1, 2017
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)Noura Radwan, Ryan Phillips, Ashley Ross, et al.
Prostate Cancer and Prostatic Diseases|January 11, 2022
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomicsPhilip Sutera, Kim Van Der Eecken, Amar U Kishan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2023
WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate CancerPhilip Sutera, Matthew P Deek, Kim Van der Eecken, et al.
The New England Journal of Medicine|June 1, 2026
Perioperative Apalutamide in High-Risk Localized Prostate CancerMary-Ellen Taplin, Martin Gleave, Neal D Shore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical ProstatectomyR Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
Ebiomedicine|May 7, 2018
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate CancerLingjian Yang, Darren Roberts, Mandeep Takhar, et al.
European Urology|March 24, 2017
Stromal Gene Expression is Predictive for Metastatic Primary Prostate CancerFan Mo, Dong Lin, Mandeep Takhar, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2019
Physiologically-Based Pharmacokinetic Modeling of Fluconazole Using Plasma and Cerebrospinal Fluid Samples From Preterm and Term InfantsJacqueline G Gerhart, Kevin M Watt, Andrea Edginton, et al.
The Journal of Urology|August 6, 2018
A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III)E David Crawford, Phillip J Koo, Neal Shore, et al.
Neoplasia (New York, N.Y.)|August 28, 2016
Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate CancerSudhanshu Shukla, Xiang Zhang, Yashar S Niknafs, et al.
BMC Cancer|July 1, 2017
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)Noura Radwan, Ryan Phillips, Ashley Ross, et al.
Prostate Cancer and Prostatic Diseases|January 11, 2022
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomicsPhilip Sutera, Kim Van Der Eecken, Amar U Kishan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2023
WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate CancerPhilip Sutera, Matthew P Deek, Kim Van der Eecken, et al.
The New England Journal of Medicine|June 1, 2026
Perioperative Apalutamide in High-Risk Localized Prostate CancerMary-Ellen Taplin, Martin Gleave, Neal D Shore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical ProstatectomyR Jeffrey Karnes, Vidit Sharma, Voleak Choeurng, et al.
Ebiomedicine|May 7, 2018
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate CancerLingjian Yang, Darren Roberts, Mandeep Takhar, et al.
European Urology|March 24, 2017
Stromal Gene Expression is Predictive for Metastatic Primary Prostate CancerFan Mo, Dong Lin, Mandeep Takhar, et al.
Pageof 8